首页 | 本学科首页   官方微博 | 高级检索  
检索        


The role of integrin antagonists in the treatment of inflammatory bowel disease
Abstract:Introduction: Ulcerative colitis (UC) and Crohn’s disease are chronic inflammatory diseases of the bowel associated with complex inflammatory cascades within the mucosal lining of the gut.

Areas covered: INTEGRINS and their use as therapies in UC and Crohn’s.

Expert Opinion: The anti-adhesion molecules are a welcome addition to the armamentarium of medical therapies for inflammatory bowel disease.
Keywords:Crohn’s disease  immunomodulator  inflammation  integrin  natalizumab  ulcerative colitis  vedolizumab
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号